
Indexed in
License and use

Grant support
The IMPROVE project is an Innovative Health Initiative project that has been granted by the European Commission under Grant agreement ID:101132847.
Using patient-generated health data more efficient and effectively to facilitate the implementation of value-based healthcare in the EU - Innovation report
Publicated to:Computational And Structural Biotechnology Journal. 24 672-678 - 2024-12-01 24(), DOI: 10.1016/j.csbj.2024.10.026
Authors: Folkvord, Frans; Carlson, Jim Ingebretsen; Ottaviano, Manuel; Carvajal, Diego; Gonzalez, Liss Hernandez; van de Schoot, Rens; Turk, Eva; Piera-Jimenez, Jordi; Pontes, Caridad; Ramiro-Pareta, Marina; Carot-Sans, Gerard; Podovsovnik, Eva; Levasic, Vesna; Scheckenbach, Kathrin; Wagenmann, Martin; Szpisjak, Aron; Eliasen, Bogi; Wakim, Joe-Max; Ernst, Martin; Prinzellner, Yvonne; Bol, Nadine; He, Linwei; Krahmer, Emiel; Navarro, Claudia; Juan, Laia; Guerri, Davide; Pinna, Laura; Genovese, Carmela; Benetti, Luciano; Macagnano, Chiara; Chiarugi, Franco; Peeters, Johannes; Pedulla, Ludovico; Brichetto, Giampaolo; Zaratin, Paola; Peschke, Seldag Gunes; Peschke, Lutz; Fico, Giuseppe
Affiliations
Abstract
Healthcare services and products are rapidly changing due to the development of new technologies, offering relevant solutions to improve patient outcomes. Patient-Generated Health Data and knowledge-sharing across the European Union (EU) has a great potential of making healthcare provision more effective and efficient by putting the patient at the centre of the healthcare process. While such initiatives have been taken before, a uniting and overarching approach is still missing. The EU-funded IMPROVE project will develop an evidencebased and actual framework to effectively leverage the added value of people-centred integrated healthcare solutions, using predominantly PROMs, PPI, PREMs, and other Patient-Generated Health Data (PGHD). As a result, the project facilitates the effective and efficient implementation of Value-Based Healthcare across the EU by putting the patient central in the healthcare process.
Keywords
Quality index
Bibliometric impact. Analysis of the contribution and dissemination channel
The work has been published in the journal Computational And Structural Biotechnology Journal due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Biophysics. Notably, the journal is positioned above the 90th percentile.
Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.
Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-07-24:
- WoS: 1
- Scopus: 1
Impact and social visibility
Leadership analysis of institutional authors
This work has been carried out with international collaboration, specifically with researchers from: Austria; Denmark; Germany; Italy; Netherlands; Slovenia; Turkey.
There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (FICO, GIUSEPPE).